Period23 Oct 2023

Media coverage

1

Media coverage

  • TitleFDA Approves First Subcutaneous Infliximab Product
    Media name/outletCenter for Biosimilars, The
    Country/TerritoryUnited States
    Date23/10/23
    PersonsJean-Frédéric Colombel